ライフサイエンスコーパス: pulmonary artery catheter

1 e metabolic testing period with an oximetric pulmonary artery catheter.

2 jects 2-mL boluses of saline into a standard pulmonary artery catheter.

3 ction were determined via a rapid thermistor pulmonary artery catheter.

4 mplantation with a rapid-response thermistor pulmonary artery catheter.

5 mic variables were obtained with a Swan-Ganz pulmonary artery catheter.

6 s were monitored with an arterial line and a pulmonary artery catheter.

7 ous oxygen saturation with parameters from a pulmonary artery catheter.

8 time of admission and before removal of the pulmonary artery catheter.

9 ls evaluating the safety and efficacy of the pulmonary artery catheter.

10 dilution cardiac output measurements using a pulmonary artery catheter.

11 logous information to that gathered from the pulmonary artery catheter.

12 eight patients with HF were monitored with a pulmonary artery catheter.

13 Hemodynamic data were obtained using a pulmonary artery catheter.

14 ventilated intensive-care-unit patients with pulmonary artery catheters.

15 ted with femoral arterial and thermodilution pulmonary artery catheters.

16 r to have similar accuracy as thermodilution pulmonary artery catheters.

17 A total of 24 patients had pulmonary artery catheters.

18 elopment of policies for the rational use of pulmonary artery catheters.

19 and interpreting information from the use of pulmonary artery catheters.

20 e care unit length of stay compared with the pulmonary artery catheter algorithm in nonseptic shock b

21 ardiac output was measured simultaneously by pulmonary artery catheter and aortic transpulmonary ther

22 obtained immediately after insertion of the pulmonary artery catheter and repeated 4 and 8 hrs later

23 rs) were instrumented with radial artery and pulmonary artery catheters and performed moderate cycle

24 d ventilation (PLV) are often monitored with pulmonary artery catheters and receive positive end-expi

25 uge lumens), the proximal infusion port of a pulmonary artery catheter, and a 9-Fr introducer sheath,

26 venous extracorporeal life support access, a pulmonary artery catheter, and a carotid artery catheter

27 strumented with a carotid artery catheter, a pulmonary artery catheter, and a tracheostomy tube and s

28 The efficacy and safety of the pulmonary artery catheter are under scrutiny because of

29 ue to insertion of a central catheter, not a pulmonary artery catheter; b) continuous monitoring of l

30 A modified pulmonary artery catheter capable of continuous monitori

31 After placement of a pulmonary artery catheter, carotid arterial line, Foley

32 PICCs and from 7-Fr, 16-gauge, 18-gauge, and pulmonary artery catheter CICCs, all with continuous pre

33 Despite this, pulmonary artery catheters continue to be used, especial

34 t of a jugular bulb catheter, placement of a pulmonary artery catheter, critical care consultation, t

35 et, and provide appropriate intervention for pulmonary artery catheter data.

36 In vitro, heparin release of the pulmonary artery catheters decreased significantly after

37 lectron microscopic images of heparin-bonded pulmonary artery catheters demonstrate thrombus formatio

38 ongoing programmatic educational efforts; e) pulmonary artery catheter-derived data need to be used w

39 A treatment protocol for the use of pulmonary artery catheter-derived variables is proposed

40 incorrect interpretation and application of pulmonary artery catheter-derived variables; and f) lack

41 A pulmonary artery catheter designed to measure right vent

42 zed trials have demonstrated that use of the pulmonary artery catheter does not improve outcomes in p

43 ivered into the right atrium via a multiport pulmonary artery catheter during continuous hemodynamic

44 of mechanical ventilation, vasopressors or a pulmonary artery catheter during the ICU stay, and the d

45 uation Study of Congestive Heart Failure and Pulmonary Artery Catheter Effectiveness) trial at hospit

46 s relating to the efficacy and safety of the pulmonary artery catheter, especially consensus document

47 Indwelling arterial and pulmonary artery catheters facilitated monitoring of hem

48 Animals were instrumented with a pulmonary artery catheter, femoral arterial and venous c

49 atheter for blood pressure measurement and a pulmonary artery catheter for bolus thermodilution.

50 tic peptide are reliable alternatives to the pulmonary artery catheter for diagnosing weaning-induced

51 y interpret derived and measured data from a pulmonary artery catheter for optimal care of these diff

52 ery occlusion pressure (<18-20 mm Hg) in the pulmonary artery catheter group for 72 hrs after enrollm

53 study, and there still may be a role for the pulmonary artery catheter in advanced heart failure.

54 A meta-analysis demonstrated that use of the pulmonary artery catheter in critically ill patients had

55 guided by transpulmonary thermodilution vs. pulmonary artery catheter in shock did not affect ventil

56 a 9-Fr introducer sheath, with and without a pulmonary artery catheter in the lumen.

57 rapeutic efficacy of interventions guided by pulmonary artery catheters in a variety of clinical sett

58 ontraindicated (1B); avoiding routine use of pulmonary artery catheters in ALI/ARDS (1A); to decrease

59 to 6.2% (2006-2008; p < 0.001); insertion of pulmonary artery catheters in ICU decreased from 4.2% to

60 Use of pulmonary artery catheters in ICU patients has declined

61 anically ventilated patients with fiberoptic pulmonary artery catheters in place were randomly assign

62 8 common atrial, and 24 right ventricular or pulmonary artery catheters) in 351 PICU patients were st

63 06-2008, ICUs in the top quartile for in-ICU pulmonary artery catheter insertion (3.4-25.0% of patien

64 ing attempted central venous cannulation for pulmonary artery catheter insertion mandates catheter re

65 d t tests and factors associated with in-ICU pulmonary artery catheter insertion using multilevel mix

66 rombus formation on the balloon 24 hrs after pulmonary artery catheter insertion, increasing dramatic

67 raphic studies; number of central venous and pulmonary artery catheter insertions; number of complete

68 Hemodynamic monitoring of patients with a pulmonary artery catheter is controversial because there

69 The future of the pulmonary artery catheter is questioned; physicians must

70 Multiple studies suggest that routine use of pulmonary artery catheters is not beneficial in critical

71 cal situations in heart failure in which the pulmonary artery catheter may be useful, however.

72 Transpulmonary thermodilution (vs. pulmonary artery catheter) monitoring was associated wit

73 eline and transpulmonary thermodilution (vs. pulmonary artery catheter) monitoring was associated wit

74 undred thirty-five consecutive patients with pulmonary artery catheters, of whom 35 were excluded bec

75 spiratory arrest, intra-aortic balloon pump, pulmonary artery catheter or pacemaker placement, revasc

76 Current methods use invasive pulmonary artery catheters or two-dimensional (2-D) echo

77 (arterial catheter, central venous catheter, pulmonary artery catheter, or peripherally inserted cent

78 ptom improvement and after therapy guided by pulmonary artery catheters (p = 0.034).

79 rgery patients using both the thermodilution pulmonary artery catheter (PAC) and multicomponent nonin

80 The impact of a strategy using pulmonary artery catheter (PAC) guidance on WRF and outc

81 Over the past 30 years the pulmonary artery catheter (PAC) has become a widely used

82 ies have observed an increase in the rate of pulmonary artery catheter (PAC) use in heart failure adm

83 ined whether the preoperative placement of a pulmonary artery catheter (PAC) with optimization of hem

84 tent pulmonary artery thermodilution using a pulmonary artery catheter (PAC-CO) with regard to accura

85 cular(LV) systolic function (E-function) and pulmonary artery catheter(PAC) assessment of hemodynamic

86 alance between the benefits and the risks of pulmonary-artery catheters (PACs) has not been establish

87 al ICUs (p = 0.057) were more likely to have pulmonary artery catheters placed in ICU.

88 and hospitals in the top quartile for in-ICU pulmonary artery catheter placement (vs the bottom quart

89 arriers include a) increased patient risk of pulmonary artery catheter placement; b) ability to measu

90 for drawing blood; contamination shields for pulmonary artery catheters; povidone-iodine ointment app

91 by transducing a peripheral intravenous and pulmonary artery catheter, respectively, after zeroing a

92 modilution cardiac output measurements via a pulmonary artery catheter should not be done during the

93 lusions were performed with a balloon-tipped pulmonary artery catheter that housed pressure transduce

94 ion Effectiveness trial, the addition of the pulmonary artery catheter to careful clinical assessment

95 s, there is no indication for routine use of pulmonary artery catheters to adjust therapy during hosp

96 2, 95% confidence interval [CI] 1.13, 1.55), pulmonary artery catheter use (RR 1.56, 95% CI 1.30, 1.8

97 Our objective was to assess recent pulmonary artery catheter use across ICUs and identify f

98 For 2006-2008, we compared pulmonary artery catheter use across ICUs.

99 rns of worsened patient outcome secondary to pulmonary artery catheter use and demonstrably inadequat

100 It also offers guidelines on when pulmonary artery catheter use could be considered in pat

101 Total pulmonary artery catheter use decreased from 10.8% of pa

102 Trends in pulmonary artery catheter use from 2001 to 2008 were ass

103 a prospective, randomized clinical trial on pulmonary artery catheter use has been proposed.

104 given high priority for clinical trials were pulmonary artery catheter use in persistent/refractory c

105 variables; and f) lack of proven benefit of pulmonary artery catheter use in the overall management

106 Age, systolic blood pressure with shock, pulmonary artery catheter use, pulmonary capillary wedge

107 ith variation in practice patterns regarding pulmonary artery catheter use.

108 recommendations regarding actions to improve pulmonary artery catheter utility and safety.

109 A pulmonary artery catheter was inserted, a magnetic flow

110 A quadrilumen thermodilution pulmonary artery catheter was placed in minipigs via the

111 measured using thermodilution (TDCO) when a pulmonary artery catheter was present.

112 A pulmonary artery catheter was used for 831 patients (8.1

113 C), critically injured patients requiring a pulmonary artery catheter were randomized to a rapid rew

114 Twenty patients with an existing pulmonary artery catheter were studied in a multidiscipl

115 ted with intensive medical therapy guided by pulmonary artery catheter were studied.

116 When only data from patients with pulmonary artery catheters were analyzed and pulmonary a

117 ctal thermometers were calibrated daily, and pulmonary artery catheters were calibrated on removal fr

118 Pulmonary artery catheters were inserted in critically i

119 After a median sternotomy, two pulmonary artery catheters were inserted via the jugular

120 Pulmonary artery catheters were placed for hemodynamic m

121 Pulmonary artery catheters were placed in 11 subjects fo

122 Arterial, venous, and pulmonary artery catheters were placed.

123 Intravenous, femoral artery, and pulmonary artery catheters were placed.

124 Pulmonary artery catheters were removed after 24, 48, 72

125 g) was administered to all dogs via the left pulmonary artery catheter, whereas the right lower lobe

126 d systolic function were instrumented with a pulmonary artery catheter within 48 h of admission.

127 The P(PAO) was measured using a pulmonary artery catheter zeroed to midaxillary level.